Cardiometabolic reprogramming drives right ventricular dysfunction in pulmonary arterial hypertension:Novel mechanisms and therapeutic implicationsOA
Cardiometabolic reprogramming drives right ventricular dysfunction in pulmonary arterial hypertension:Novel mechanisms and therapeutic implications
Saihu Liu;Mari Okazaki;Yanling Wu
Key Laboratory for Traditional Chinese Korean Medicine Research(State Ethnic Affairs),Key Laboratory of Natural Medicines of the Changbai Mountain(Ministry of Education),College of Pharmacy,Yanbian University,Yanji 133002,ChinaLaboratory of Pharmacology,Faculty of Pharmaceutical Sciences,Josai University,Saitama 350-0295,JapanKey Laboratory for Traditional Chinese Korean Medicine Research(State Ethnic Affairs),Key Laboratory of Natural Medicines of the Changbai Mountain(Ministry of Education),College of Pharmacy,Yanbian University,Yanji 133002,China
cardiometabolic reprogrammingmitochondrial dysfunctionpulmonary arterial hypertensionright ventricular dysfunctionsingle-cell multi-omics technology
cardiometabolic reprogrammingmitochondrial dysfunctionpulmonary arterial hypertensionright ventricular dysfunctionsingle-cell multi-omics technology
《中草药（英文版）》 2026 (3)
494-498,5
The authors express their gratitude to Department of Science and Technology of Jilin Province(No.20250205012GH),National Natural Science Foundation of China(Nos.82560813,81973555).
评论